Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7519755
Reference Type
Journal Article
Subtype
Review
Title
Role of non-coding sequence variants in cancer
Author(s)
Khurana, E; Fu, Y; Chakravarty, D; Demichelis, F; Rubin, MA; Gerstein, M
Year
2016
Is Peer Reviewed?
1
Journal
Nature Reviews. Genetics
ISSN:
1471-0056
EISSN:
1471-0064
Volume
17
Issue
2
Page Numbers
93-108
Language
English
PMID
26781813
DOI
10.1038/nrg.2015.17
Abstract
Patients with cancer carry somatic sequence variants in their tumour in addition to the germline variants in their inherited genome. Although variants in protein-coding regions have received the most attention, numerous studies have noted the importance of non-coding variants in cancer. Moreover, the overwhelming majority of variants, both somatic and germline, occur in non-coding portions of the genome. We review the current understanding of non-coding variants in cancer, including the great diversity of the mutation types--from single nucleotide variants to large genomic rearrangements--and the wide range of mechanisms by which they affect gene expression to promote tumorigenesis, such as disrupting transcription factor-binding sites or functions of non-coding RNAs. We highlight specific case studies of somatic and germline variants, and discuss how non-coding variants can be interpreted on a large-scale through computational and experimental methods.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity